Transcriptomics

Dataset Information

0

Tissue-resident CXCR4+ macrophage as a poor prognosis signature promotes pancreatic ductal adenocarcinoma progression

ABSTRACT: In this study, we explored the CXCR4+ macrophages subset on its prognosis value, immune profile and distinct function in pancreatic cancer progression. RNA-seq analysis is performed to find the distinct characters of mouse tumor-derived Cxcr4+ macrophages.

ORGANISM(S): Mus musculus

PROVIDER: GSE206570 | GEO | 2022/06/24

REPOSITORIES: GEO

Json Xml

Similar Datasets

Genomics Tissue-resident CXCR4+ macrophage as a poor prognosis signature promotes pancreatic ductal adenocarcinoma progression
| PRJNA851389 | ENA
Unknown Coexpression of EGFR and CXCR4 predicts poor prognosis in resected pancreatic ductal adenocarcinoma.
| S-EPMC4332630 | biostudies-literature
Unknown Decreased LKB1 predicts poor prognosis in Pancreatic Ductal Adenocarcinoma.
| S-EPMC4650682 | biostudies-other
Unknown Overexpression of MYEOV predicting poor prognosis in patients with pancreatic ductal adenocarcinoma.
| S-EPMC7469688 | biostudies-literature
Unknown Constitutive IRAK4 Activation Underlies Poor Prognosis and Chemoresistance in Pancreatic Ductal Adenocarcinoma.
| S-EPMC5378683 | biostudies-literature
Unknown PALB2 upregulation is associated with a poor prognosis in pancreatic ductal adenocarcinoma.
| S-EPMC7856690 | biostudies-literature
Unknown Weak HIF-1alpha expression indicates poor prognosis in resectable pancreatic ductal adenocarcinoma.
| S-EPMC6033289 | biostudies-literature
Unknown High levels of serum glypican-1 indicate poor prognosis in pancreatic ductal adenocarcinoma.
| S-EPMC6246926 | biostudies-literature
Unknown A glycosyltransferase gene signature to detect pancreatic ductal adenocarcinoma patients with poor prognosis.
| S-EPMC8379629 | biostudies-literature
Transcriptomics CXCR4 overexpression in chronic lymphocytic leukemia associates with poorer prognosis: a prospective, single-center, observational study
2024-01-26 | GSE254015 | GEO